Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2535024 | European Journal of Pharmacology | 2008 | 4 Pages |
Abstract
The ATP-binding cassette (ABC) transporter ABCC1, or multidrug resistance-related protein 1 (MRP1) is implicated in Phase II metabolism and multidrug resistance as it effluxes substrate anticancer drugs. As cannabinoids inhibit two related ABC transporters, P-glycoprotein and ABCG2, here we examined whether they also inhibit ABCC1. Indeed, the cannabinoids enhanced the intracellular accumulation of two ABCC1 substrates, Fluo3 and vincristine, in ovarian carcinoma cells over-expressing ABCC1 (2008/MRP1) with a rank order of potency: cannabidiol > cannabinol > Δ9-tetrahydrocannabinol. Cannabinoid inhibition of ABCC1 was confirmed using insect cell membrane MRP1 ATPase assays. These results demonstrate that cannabinoids inhibit ABCC1.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Michelle L. Holland, John D. Allen, Jonathon C. Arnold,